Latest news
SciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 23:34:05 GMTSciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center - TipRanksTipRanks · Thu, 06 Aug 2026 06:21:58 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTSciSparc Announces NeuroThera Labs Achieves Milestone in Quantum-Enabled Clinical Trial Data Analytics Platform - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 12:30:00 GMTNeuroThera's quantum platform takes clinical data to interpretable insights in simulation - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTSciSparc's Quantum Workflow Evaluated on S&P 500 Company Platform - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTSciSparc (Nasdaq: SPRC) targets agentic AI, advances quantum platform - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT